Relief Therapeutics Holding AG (RLFTF)

[J-Belfort]

“We look forward to working with the FDA in hopes of providing critically ill patients with a new medicine that will increase their chances of recovery, enabling them to leave the hospital and return to their families significantly sooner.”
- Jonathan Javitt, MD CEO of NRx

“We look forward to working with the FDA in hopes of providing critically ill patients with a new medicine that will increase their chances of recovery, enabling them to leave the hospital and return to their families significantly sooner.” - Jonathan Javitt, MD CEO of NRx

— NRx Pharmaceuticals (@NRxPharma) June 1, 2021